Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
45 active Medicare policies list M54.81, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
8 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M54.81 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Cryoanalgesia and Therapeutic Cold | Mar 16, 2023 | Covered |
| Headaches: Invasive Procedures | Feb 20, 2024 | Covered |
| Pulsed Radiofrequency | Sep 20, 2023 | Covered |
| Policy | Effective | Status of M54.81 |
|---|---|---|
| Implantation of Occipital, Supraorbital or Trigeminal Nerve Stimulation Devices (and Related Procedures) |
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Mar 5, 2026
JL · Effective Oct 1, 2025
J9 · Effective Oct 1, 2025
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 30, 2025
National · Effective Oct 25, 2026
National · Effective Oct 25, 2026
National · Effective Oct 25, 2026
National · Effective Oct 25, 2026
National · Effective Oct 25, 2026
National · Effective Oct 23, 2025
National · Effective Oct 16, 2025
| Oct 1, 2026 |
| Not covered |
| Occipital and Sphenopalatine Ganglion Nerve Block Therapy for the Treatment of Headache and Neuralgia | Oct 1, 2026 | Not covered |
|---|
| Surgical and Ablative Treatments for Chronic Headaches | Apr 15, 2026 | Not covered |
|---|
| Policy | Effective | Status of M54.81 |
|---|---|---|
| Intraoperative Monitoring | Sep 15, 2025 | Covered |